Talariant

Origin: MO | Grant Awarded: 2014 | Status: Exited

What is Talariant?

Talariant is a bio-tech company that spun out of the BioDesign and Innovation Program at the University of Missouri – Columbia. Talariant is targeting pharmaceutical aerosol applications and its first product is a novel delivery mechanism to enhance efficiency in ophthalmic surgery.

Company Leadership

Kyle Rood

President

Kyle earned his degree in Bioengineering and Biomedical Engineering from University of Missouri-Columbia in 2011, and holds a Masters Degree in Bioengineering and Biomedical Engineering from the University of Missouri-Columbia. Kyle is a bioengineer with a talent for finding medical solutions and developing devices that can improve healthcare, and brings previous work experience for the University of Missouri to his position as President of Talariant.

Connect on LinkedIn →

Clint Matthews

Chief Executive Officer

Clint earned his degree in Atmospheric Science from University of Missouri-Columbia in 2005, and holds a MBA from University of Missouri-Columbia, College of Business. Clint is a natural entrepreneur and business developer with a background in the hard sciences and medical field. He currently serves as a Co-Founder at Cardioptimus, and brings previous experience with AmiraLin LLC to his work as CEO of Talariant.

Connect on LinkedIn →

Involved Industries

Be a Part of the Movement

We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.